sotigalimab,doxorubicin
apexigen
['doxorubicin', 'apex', 'sotigalimab', 'sarcoma', 'apexigen', '$ibb', '$xbi', '$apgn']
$apgn apexigen reports promising phase 2 results for sotigalimab, a cd40 agonist antibody, combined with doxorubicin in advanced soft tissue sarcoma patients at asco 2023 meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt